Stay updated on Oral Elsubrutinib and Upadacitinib in Lupus Clinical Trial
Sign up to get notified when there's something new on the Oral Elsubrutinib and Upadacitinib in Lupus Clinical Trial page.

Latest updates to the Oral Elsubrutinib and Upadacitinib in Lupus Clinical Trial page
- Check3 days agoChange DetectedThe page’s revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a platform/release change rather than any edit to the study history details.SummaryDifference0.1%

- Check10 days agoChange DetectedRevision: v3.5.2 was added and Revision: v3.5.0 was removed.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check39 days agoChange DetectedA new Revision: v3.5.0 was added and an existing Revision: v3.4.3 was removed from the study's record history.SummaryDifference0.1%

- Check46 days agoChange DetectedRevision v3.4.3 was added and v3.4.2 was removed from the study record history.SummaryDifference0.1%

- Check53 days agoChange DetectedMultiple version updates show additions and deletions across sections like Study Status, Description, Arms/Interventions, and Location details, indicating evolving data over time. This reflects how the record has changed from older to newer versions.SummaryDifference0.1%

- Check75 days agoChange DetectedAdded revision note v3.4.2; removed the funding-lapse notice and the v3.4.1 revision. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

Stay in the know with updates to Oral Elsubrutinib and Upadacitinib in Lupus Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral Elsubrutinib and Upadacitinib in Lupus Clinical Trial page.